Assenagon Asset Management S.A. Takes Position in Integer Holdings Co. (NYSE:ITGR)

Assenagon Asset Management S.A. acquired a new position in shares of Integer Holdings Co. (NYSE:ITGR - Free Report) in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor acquired 13,879 shares of the medical equipment provider's stock, valued at approximately $1,375,000.

Several other institutional investors and hedge funds have also bought and sold shares of the company. Raymond James & Associates lifted its holdings in shares of Integer by 20.3% in the fourth quarter. Raymond James & Associates now owns 48,946 shares of the medical equipment provider's stock worth $4,850,000 after acquiring an additional 8,246 shares during the last quarter. Legacy Wealth Asset Management LLC bought a new position in shares of Integer in the fourth quarter worth about $239,000. Vanguard Group Inc. lifted its holdings in shares of Integer by 0.4% in the third quarter. Vanguard Group Inc. now owns 3,843,992 shares of the medical equipment provider's stock worth $301,484,000 after acquiring an additional 15,300 shares during the last quarter. Wesbanco Bank Inc. lifted its holdings in shares of Integer by 92.5% in the third quarter. Wesbanco Bank Inc. now owns 13,318 shares of the medical equipment provider's stock worth $1,045,000 after acquiring an additional 6,400 shares during the last quarter. Finally, Deutsche Bank AG increased its stake in shares of Integer by 13.5% in the third quarter. Deutsche Bank AG now owns 16,343 shares of the medical equipment provider's stock valued at $1,282,000 after buying an additional 1,939 shares during the period. Institutional investors own 99.29% of the company's stock.

Integer Trading Down 0.0 %

NYSE:ITGR traded down $0.05 on Friday, reaching $114.97. 355,414 shares of the stock traded hands, compared to its average volume of 275,054. The firm has a market capitalization of $3.84 billion, a price-to-earnings ratio of 42.74, a price-to-earnings-growth ratio of 1.45 and a beta of 1.10. The company's 50 day moving average is $109.11 and its 200-day moving average is $95.83. The company has a current ratio of 2.80, a quick ratio of 1.71 and a debt-to-equity ratio of 0.64. Integer Holdings Co. has a 1-year low of $69.40 and a 1-year high of $118.15.

Integer (NYSE:ITGR - Get Free Report) last announced its quarterly earnings data on Thursday, February 15th. The medical equipment provider reported $1.39 EPS for the quarter, topping the consensus estimate of $1.34 by $0.05. The company had revenue of $413.15 million during the quarter, compared to the consensus estimate of $409.04 million. Integer had a net margin of 5.68% and a return on equity of 10.80%. The company's quarterly revenue was up 10.9% on a year-over-year basis. During the same quarter last year, the firm posted $1.11 EPS. Equities research analysts anticipate that Integer Holdings Co. will post 5.28 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

Several research analysts have recently issued reports on ITGR shares. Benchmark upped their price objective on Integer from $105.00 to $130.00 and gave the company a "buy" rating in a research note on Thursday, March 28th. CL King started coverage on Integer in a research note on Thursday, March 14th. They issued a "buy" rating and a $137.00 price objective for the company. Finally, KeyCorp lowered their price objective on Integer from $125.00 to $123.00 and set an "overweight" rating for the company in a research note on Friday, February 16th. Three research analysts have rated the stock with a hold rating and three have issued a buy rating to the company's stock. According to MarketBeat, Integer currently has a consensus rating of "Moderate Buy" and an average price target of $114.40.

Integer Company Profile

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.